Renal stone disease

Nephron - Physiology

Volumn 118, Issue 1, 2010, Pages

  Sayer, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Calcium sensing receptor; Genetic defects; Genome wide association studies; Hypercalciuria; Hyperoxaluria; Nephrolithiasis; Renal stone disease

Indexed keywords

CALCITRIOL; CALCIUM OXALATE; CALCIUM SALT; CALCIUM SENSING RECEPTOR; CLAUDIN 11; CYCLIC AMP; CYSTINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYOXYLIC ACID; OSTEOPONTIN; TAMM HORSFALL GLYCOPROTEIN; URIC ACID; VITAMIN D RECEPTOR;

ALLELE; BARTTER SYNDROME; CALCIUM OXALATE STONE; CALCIUM STONE; CALCIUM URINE LEVEL; CYSTINURIA; GENETIC DISORDER; GENETIC SCREENING; HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA; HEREDITY; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERPARATHYROIDISM; HYPERURICOSURIA; HYPOPHOSPHATEMIA; IDIOPATHIC DISEASE; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE ACIDOSIS; MACROMOLECULE; METABOLIC ACIDOSIS; MOLECULAR GENETICS; NEPHROLITHIASIS; NONHUMAN; OSTEOPOROSIS; OXALOSIS 1; PATHOGENESIS; PHOSPHATURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; XANTHINURIA;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY; KIDNEY CALCULI; MODELS, GENETIC;

EID: 78649970188     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320902     Document Type: Review

References (52)

1. Stamatelou KK, Francis ME, Jones CA, Ny-berg L M, Curhan G C: Timetrendsin reported prevalence of kidney stones in the United States: 1976 -1994. Kidney Int 2003; 63: 1817-1823.
2. Uribarri J, Oh MS, Carroll HJ: The first kidney stone. Ann Intern Med 1989; 111:1006-1009.
3. Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B: Family history of renal stones in recurrent stone patients. Br J Urol 1985; 57: 370-374 .
4. Curhan GC, Willett WC, Knight EL, Stamp-fer MJ: Dietary factors and the risk of incident kidney stones in younger women: Nurs-es' Health Study II. Arch Intern Med 2004; 164:885-891.
5. Sritippayawan S, Borvornpadungkitti S, Paemanee A, Predanon C, Susaengrat W, Chuawattana D, Sawasdee N, Nakjang S, Pongtepaditep S, Nettuwakul C, Rungroj N, Vasuvatta kul S, Malasit P, Yench itsoma-nus PT: Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population. Urol Res 2009; 37:141-146.
6. Goldfarb DS, Fischer ME, Keich Y, Goldberg J: A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005; 67: 10 53 -10 61.
7. Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD: Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 2002; 103:259-265.
8. Loredo-Osti JC, Roslin NM, Tessier J, Fuji-wara TM, Morgan K, Bonnardeaux A: Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 2005; 68: 966-971.
9. Pak CY: Kidney stones. Lancet 1998; 351: 1797-1801.
10. Polito C, La Manna A, Nappi B, Villani J, Di Toro R: Idiopathic hypercalciuria and hy-peruricosuria: family prevalence of neph-rolithiasis. Pediatr Nephrol 2000; 14:1102-1104.
11. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d'Ancona FC, den Heijer M, Franzson L, Christiansen C, Alexandersen P, Rafnar T, K ristja nsson K, Sig urd sson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K: Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009; 41: 926-930.
12. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB: Rare variants create synthetic genome-wide associations. PLoS Biol 2010; 8:e1000294.
13. Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, Itoh Y, Tozawa K, Hayashi Y, Kohri K: Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephroli-thiasis model mouse: detection of stone-preventive factors and involvement of mac-rophage activity. J Bone Miner Res 2009; 24: 908-924.
14. Bushinsky DA: Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hy-pertens 1999; 8:479-488.
15. Yao JJ, Bai S, Karnauskas AJ, Bushinsky DA, Favus MJ: Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvita-min D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 2005; 16: 1300-1308.
16. Grynpas M, Waldman S, Holmyard D, Bush-insky DA: Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength. J Bone Miner Res 2009; 24:1420-1426.
17. Wiessner JH, Garrett MR, Roman RJ, Man-del NS: Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains. Am J Physiol Renal Physiol 2009; 297:F301-F306.
18. Gambaro G, Fabris A, Puliatta D, Lupo A: Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 2006; 34: 102-107.
19. Torres VE, Wilson DM, Hattery RR, Segura JW: Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993; 22:513-519.
20. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 2007; 369:1287-1301.
21. Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP: Evaluation of nephro-lithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 838-844.
22. Hildebrandt F, Sayer JA, Jungers P, Grunfeld J-P: Nephronophthisis- medullary cystic and medullary sponge kidney disease; in Schrier RW (ed): Diseases of the Kidney and Urinary Tract. Philadelphia, Lippincott Williams & Wilkins, 2006.
23. +- ATPase genes. Nephrol Dia l Transplant 2009; 24: 2734 -273 8 .
24. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, Goodship JA, Goodship TH, Bakalin-ova-Pugh D, Russell GI, Woolf AS, Nicholls AJ, Hattersley AT: Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int 2002; 61:1243-1251.
25. Sayer JA, Simmons NL: Urinary stone formation: Dent's disease moves understanding forward. Exp Nephrol 2002; 10:176-181.
26. Scheinman SJ, Cox JP, Lloyd SE, Pearce SH, Salenger PV, Hoopes RR, Bushinsky DA, Wrong O, Asplin JR, Langman CB, Norden AG, Thakker RV: Isolated hypercalciuria with mutation in CLCN5: relevance to idio-pathic hypercalciuria. Kidney Int 20 00; 57: 232-239.
27. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW: Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997; 99: 1399-1405.
28. Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Fer-raretto A, Cusi D, Bianchi G, Soldati L: R990g polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 2007; 71: 1155-1162.
29. Hamilton DC, Grover VK, Smith CA, Cole DE: Heterogeneous disease modeling for Hardy-Weinberg disequilibrium in case-control studies: application to renal stones and calcium-sensing receptor polymorphisms. Ann Hum Genet 2009; 73: 176-183.
30. Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L: Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 2010; 25:2245-2252.
31. Ferreira LG, Costa Pereira A, Heilberg IP: Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciu-ric stone-forming patients. Nephron Clin Pract 2009; 114:c135-c144.
32. Favus MJ, Karnauskas AJ, Parks JH, Coe FL: Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idio-pathic hypercalciuria. J Clin Endocrinol Metab 2004; 89:4937-4943.
33. Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CY: Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 1995; 80: 2960-2965.
34. 2+ channel (ECAC1) in au-tosomal dominant idiopathic hypercalciuria. Nephrol Dial Transplant 2002; 17: 1614-1620.
35. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ: Gain-of-function hap-lotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 2008; 17:1613-1618.
36. Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lemke M, Padalino P, Pak CY: Identification and characterization of a gene with base substitutions associated with the absorptive hy-percalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 2002; 87: 1476-1485.
37. Cochat P, Liut kus A, Fargue S, Basmaison O, Ranchin B, Rolland MO: Primary hyperox-aluria type 1: still challenging! Pediatr Nephrol 2006; 21:1075-1081.
38. Cheong HI, Kang JH, Lee JH, Ha IS, Kim S, Komoda F, Sekine T, Igarashi T, Choi Y: Mu-tational analysis of idiopathic renal hypouri-cemia in Korea. Pediatr Nephrol 2005; 20: 886-890.
39. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, Phetdee K, Wiriyasermkul P, Kikuchi Y, Oda T, Nishiyama J, Nakamura T, Morimoto Y, Kamakura K, Sakurai Y, No-noyama S, Kanai Y, Shinomiya N: Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008; 83:744-751.
40. Okamoto N, Aruga S, Matsuzaki S, Taka-hashi S, Matsushita K, Kitamura T: Associations between renal sodium-citrate cotrans-porter (HNADC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol 2007; 14 : 344-349.
41. Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopaca-sa F, Nunziata V: Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephro-lit hiasis. J Intern Med 2003; 253: 194-200.
42. Prie D, Huart V, Bakouh N, Planelles G, Del-lis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G: Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2A sodium-phosphate co-transpor ter. N Engl J Med 2002; 347: 983-991.
43. Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prie D: NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 2008; 359:1128-1135.
44. Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Kat z R, Li M, Ya ng Q, Gud na son V, Laun-er LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Ida Chen YD, de Boer IH, Hari-tunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchen-ko YS, Hofman A, Rivadeneira F, Uitterlin-den AG, Van Duijn CM, Chasman DI, Pare G, Ridker PM, Kao WH, Witteman JC, Coresh J, Shlipak MG, Fox CS: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009, Epub ahead of print.
45. Jaggi M, Nakagawa Y, Zipperle L, Hess B: Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 2007; 35: 55-62.
46. Nishio S, Hatanaka M, Takeda H, Iseda T, Iwata H, Yokoyama M: Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glyco-protein, prothrombin F1, and osteopontin. J Am Soc Nephrol 1999; 10(suppl 14):S394-S396.
47. Gao B, Yasui T, Itoh Y, Li Z, Okada A, Tozawa K, Hayashi Y, Kohri K: Association of osteo-pont in gene haploty pes with nephrolith iasis. Kidney Int 2007; 72: 592-598.
48. Sayer JA: The genetics of nephrolithiasis. Nephron Exp Nephrol 2008; 110:e37-e43.
49. Perruzza I, Di Pietro V, Tavazzi B, Lazzarino G, Gamberini M, Barsotti P, Amorini AM, Giardina B, Balducci A: Is adenine phopho-rybosiltransferase deficiency a still underdi-agnosed cause of urolithiasis and chronic renal failure? A report of two cases in a family with an uncommon novel mutation. NDT Plus 2008; 1:292-295.
50. Bollee G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, Deteix P, Daudon M, Knebelmann B, Ceba l los-Picot I: Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 2010; 21:679-688.
51. Vernon HJ, Osborne C, Tzortzaki EG, Yang M, Chen J, Rittling SR, Denhardt DT, Buyske S, Bledsoe SB, EVan AP, Fairbanks L, Sim-monds HA, Tischfield JA, Sahota A: Aprt/ Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int 20 05; 68: 938-947.
52. Torregrossa R, Anglani F, Fabris A, Gozzini A, Tanini A, Del Prete D, Cristofaro R, Arti-foni L, Abaterusso C, Marchionna N, Lupo A, D'Angelo A, Gambaro G: Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol 2010;5:1205-1210.